Proceedings of the PSK Conference (대한약학회:학술대회논문집)
- 2002.10a
- /
- Pages.272.2-273
- /
- 2002
A NAT for reliable HBV DNA Screening of Plasma
- Kang, Hye-Na (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Noh, Hyang-Soon (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Lee, Nam-Kyoung (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Kim, Soon-Nam (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Man, Hong-Choon (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Lee, Ki-Hong (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Oh, Ho-Jung (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Yoo, Si-Hyung (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Shin, In-Soo (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Choi, Seung-Eun (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Lee, Seok-Ho (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
- Hong, Seung-Hwa (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration)
- Published : 2002.10.01
Abstract
The safety of blood and blood products is ensured by careful selection of donors. screening of donated blood and the use of validated viral inactivation and/or removal steps during the manufacture of blood products. Serologic screening procedures have substantially reduces the risk of transmission of blood-bone viruses. However, there are still residual risks despite these measures due to the inclusion of 'window period'donations. (omitted)
Keywords